Nemaura Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
sSECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act 1934
Date of Report (Date of earliest event
reported):
(Exact name of registrant as specified in charter)
(State or other jurisdiction of incorporation)
|
|
| |
| (Commission File Number) | (IRS Employer Identification No.) |
|
|
| |
| (Address of principal executive offices) | (Zip Code) | |
| Registrant’s telephone number, including area code: |
+1 | |
|
N/A (Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On February 26, 2024, Nemaura Medical Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) to vote on the following matters:
1. Election of directors
Each of the following four nominees was elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve for a term of one year and until their successors have been duly elected and qualified or until the director’s earlier death, resignation or removal.
| Nominee | For | Withheld | Broker Non-Votes | |||
| Dewan Fazlul Hoque Chowdhury | 14,150,390 | 1,283,812 | 2,585,450 | |||
| Bashir Timol | 14,096,660 | 1,337,542 | 2,585,450 | |||
| Dr. Salim Natha | 13,966,777 | 1,467,425 | 2,585,450 | |||
| Dr. Fuzail Jamall | 14,293,779 | 1,140,423 | 2,585,450 |
2. Ratification of the Company’s independent registered public accounting firm
Stockholders ratified the appointment of Weinberg and Company, P.A. as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2024, in accordance with the voting results listed below.
| For | Against | Abstain | Broker Non-Votes | |||
| 17,642,661 | 375,666 | 1,325 | N/A |
3. Approval of increase in authorized shares of the Company’s common stock
Stockholders approved an amendment to the Company’s Articles of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, from 42,000,000 shares to 62,000,000 shares, in accordance with the voting results listed below.
| For | Against | Abstain | Broker Non-Votes | |||
| 16,679,285 | 1,338,695 | 1,672 | N/A |
4. Approval of Nemaura Medical Inc. 2023 Omnibus Incentive Plan
Stockholders approved the Nemaura Medical Inc. 2023 Omnibus Incentive Plan, in accordance with the voting results listed below.
| For | Against | Abstain | Broker Non-Votes | |||
| 14,942,054 | 470,434 | 21,714 | 2,585,450 |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
Description | |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded with the Inline XBRL document | |
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEMAURA MEDICAL INC. | ||
| Date: February 26, 2024 | By: | /s/ Dewan F.H. Chowdhury |
| Dewan F.H. Chowdhury Chief Executive Officer |
||